166 related articles for article (PubMed ID: 4773984)
1. [Amantadine treatment in parkinsonism].
Holmsen R
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984
[No Abstract] [Full Text] [Related]
2. L-dopa for parkinsonism.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
[No Abstract] [Full Text] [Related]
3. [Amantadine and dexetimide in the treatment of parkinsonism].
Hakkarainen H; Viukari M
Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
[No Abstract] [Full Text] [Related]
4. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
Man'kovskii NB; Vainshtok AB; Oleinik LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's disease with amantadine].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
[No Abstract] [Full Text] [Related]
6. [Amantadine in the treatment of Parkinson's disease].
Penders C
Rev Med Liege; 1972 Dec; 27(23):835-7. PubMed ID: 4276353
[No Abstract] [Full Text] [Related]
7. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
8. [Long-time therapy of Parkinsonism with amantadine sulfate. Reply to L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsonism"].
Fünfgeld EW
Munch Med Wochenschr; 1972 Jun; 114(22):1064-5. PubMed ID: 5068021
[No Abstract] [Full Text] [Related]
9. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
10. Amantadine therapy in parkinsonism.
Forssman B; Kihlstrand S; Larsson LE
Acta Neurol Scand; 1972; 48(1):1-18. PubMed ID: 4553409
[No Abstract] [Full Text] [Related]
11. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
[No Abstract] [Full Text] [Related]
12. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
[No Abstract] [Full Text] [Related]
13. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
[No Abstract] [Full Text] [Related]
14. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985
[No Abstract] [Full Text] [Related]
15. Treatment of Parkinsonism with amantadine hydrochloride.
Pa Med; 1971 Apr; 74(4):54-5. PubMed ID: 5147644
[No Abstract] [Full Text] [Related]
16. Trial of amantadine in Parkinson's disease.
Campbell AM; Williams MJ
Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
[No Abstract] [Full Text] [Related]
17. An artist's view of drug-induced hallucinosis.
Ebersbach G
Mov Disord; 2003 Jul; 18(7):833-4. PubMed ID: 12815666
[TBL] [Abstract][Full Text] [Related]
18. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
Postma JU; Van Tilburg W
J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
20. [Amantadine in the treatment of Parkinson's disease].
Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E
Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
